Skip to main content
. 2020 Oct 1;19(7):1355–1365.e4. doi: 10.1016/j.cgh.2020.09.041

Supplementary Figure 2.

Supplementary Figure 2

Prevalence and distribution of gastrointestinal symptoms in 875 patients who were not known to have received any of the following medications that are associated with potential gastrointestinal side effects: hydroxychloroquine, chloroquine, remdesivir, oseltamivir, lopinavir/ritonavir, and interferon alpha, compared with the full cohort. COVID-19, coronavirus disease 2019.